查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830516

吻合器市场按应用、最终用途、技术、程序类型、分销管道和材料类型划分－2025-2032 年全球预测

Anastomosis Devices Market by Application, End Use, Technology, Procedure Type, Distribution Channel, Material Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年吻合器市场规模将成长至 57.1 亿美元，复合年增长率为 8.19%。

主要市场统计数据
基准年2024年 30.4亿美元
预计2025年 32.9亿美元
预测年份：2032年 57.1亿美元
复合年增长率（%） 8.19%

全面介绍当代吻合器领域，重点在于临床驱动因素、创新载体和医疗保健系统中的采购重点

随着临床对改善手术效果的需求与器械层面的快速创新相融合，吻合器领域正处于曲折点。本报告首先探讨了外科医生、医院管理人员和器械製造商如何应对日益复杂的临床、监管和商业考虑。随着器械人体工学、组织相容性材料和手术专用工具的不断改进，相关人员正在重新调整其采购和产品蓝图，以反映不断变化的临床偏好和手术工作流程。

随着微创手术成为心血管和消化器官系统领域广泛治疗的标准，器械开发商正致力于开发注重可重复性、缩短手术时间和增强组织癒合能力的系统。同时，支付方和医疗系统也更加重视基于价值的治疗结果。因此，製造商不仅要展示其技术性能，还要展示其与护理路径、培训计划和库存管理的整合。本引言概述了报告探讨的核心主题，并向读者介绍了在不久的将来影响临床应用和商业竞争的关键驱动因素。

深入分析影响吻合器市场竞争优势和采用动态的技术、临床和监管变化

吻合器市场正在经历一场变革性的转变，其驱动力来自于技术、临床实践和供应链韧性的融合。同时，可生物降解材料和复合材料的进步正在促进组织整合，并减少长期异物反应。这些技术变革并非孤立发生；它们影响培训专案、通讯协定和设备服务模式，因此需要采取整体的商业化方法。

临床上，外科医师越来越青睐能够最大程度减少组织创伤、加速復原的手术，这推动了微创手术的广泛应用。随着医院和门诊手术中心不断改进手术全期路径，以优化手术量和病患体验，器械供应商必须使其产品开发与不断发展的治疗趋势保持一致。同时，监管审查的加强和对上市后监管的加强，使得品质保证和证据生成成为商业性的必要条件。总而言之，这些趋势正在重塑竞争优势，差异化越来越依赖临床证据、综合服务和灵活应变的分销模式的结合。

深入探讨 2025 年前美国新关税政策将如何影响医疗设备供应链的製造足迹、分销策略和采购动态。

美国将于2025年开始实施新关税，这为医疗设备製造商和医疗保健系统买家的供应链和定价策略带来了复杂性。关税调整正在影响各通路的采购决策，迫使他们重新评估製造布局，并影响供应商和医疗保健系统买家之间的谈判。为此，许多製造商正在考虑近岸外包、区域组装中心和多元化采购，以缓解成本压力，同时保持品管和前置作业时间的可靠性。

除了直接成本影响外，关税还可能影响通路动态，因为它会改变直销与第三方分销的相对竞争力，并鼓励数位和线上销售管道降低中阶成本。医疗保健提供者现在会更谨慎地评估总体拥有成本，将物流风险、与材料选择相关的预期设备寿命以及潜在的合规成本纳入考虑。简言之，关税主导的变化强化了供应链敏捷性和合约弹性作为吻合器领域商业策略核心要素的重要性。

基于细分的详细洞察揭示了影响需求的临床适应症、最终使用环境、技术类型、程序方法、分销管道和材料选择

该细分提供了一个分析框架，用于理解创新和需求在临床和商业轴线上的交汇点。该结构揭示了临床适应症如何驱动器械设计的优先事项，例如管腔尺寸相容性、强化策略和止血控制。根据最终用途，市场在门诊手术中心、医院和专科诊所进行研究，揭示了基于病例组合、资本预算和消毒资源的采购行为差异。

技术细分透过手动和电动解决方案来考察市场，从而可以对易用性、训练负担和对手术时间的影响进行差异化评估。根据手术类型，市场透过微创和开放性手术方法来考察，随着微创技术在许多适应症中继续取代传统开放性手术，重点在于采用轨迹。根据销售管道，市场考察直销、线上销售和第三方经销商，重点关注通路经济性、服务期望和售后支援需求。最后，根据材料类型，市场检视可生物降解、复合材料和钛合金选项，以了解组织相容性、机械完整性和长期植入行为之间的权衡。这些细分揭示了临床需求、报销动态和营运现实的交汇点，从而创造了机会和竞争压力。

从战略区域观点美洲、欧洲、中东和非洲以及亚太地区的不同医疗保健系统如何需要不同的商业化策略和监管策略

区域动态对于产品开发、监管策略和商业扩张的策略规划至关重要。美洲的医疗保健系统由先进的三级医疗中心和社区医院组成，其综合护理网络、报销模式和捆绑支付结果驱动购买决策。这种环境有利于拥有可靠临床证据和可扩展训练计画的系统。在欧洲、中东和非洲，监管多样性和医院采购结构促使製造商寻求量身定制的打入市场策略，在重点审批和本地伙伴关係关係之间取得平衡。同时，某些市场的成本敏感度鼓励模组化产品供应和灵活的商业模式。

受外科手术能力提升、微创治疗项目扩展以及政府主导的医疗保健投资的推动，亚太市场呈现出多样化的成长和应用模式。服务这些市场的供应商通常透过将本地化製造和组装与协作培训和临床教育计划相结合来加速应用。不同地区的供应链弹性、关税影响和分销生态系统存在差异，这要求企业采用针对特定地区的策略，将监管前瞻性、战略伙伴关係和灵活的定价结构整合在一起，才能在碎片化的全球格局中取得成功。

权威的竞争动态概述，展示平台策略、临床证据产生和策略伙伴关係关係将如何决定吻合术解决方案的市场领导地位

吻合器领域的竞争态势由成熟的医疗设备公司和敏捷的专业创新者所构成。主要企业专注于开发整合器械、耗材和操作培训的平台，以与外科团队和医院系统建立稳固的合作关係。这些公司通常透过多中心研究和上市后註册来投资以取得临床证据，以证明产品的比较性能并支持报销谈判。同时，规模较小、专注于技术的参与企业则致力于利用独特的材料科学或自动化技术，探索利基应用，以解决特定的临床痛点。

伙伴关係和策略联盟正日益普遍，这使得大型机构能够利用有针对性的技术扩充产品系列，同时实现规模化和分销。同时，原始设备製造商 (OEM) 和合约製造商正在从单纯的生产合作伙伴发展成为共同开发的合作伙伴，提供设备工程、法规遵循和成本优化方面的专业知识。整体竞争格局有利于那些能够将临床可靠性与製造、供应链和客户支援方面的卓越营运相结合的公司。

为设备製造商提供可行的策略建议，以协调创新、临床证据和弹性商业模式，确保其在医疗保健环境中的持久采用

产业领导者应优先考虑采用整合方法，将产品创新与临床工作流程、供应链韧性和证据产生结合。投资强大的设备平台和直觉的使用者介面，有助于在医院和门诊环境中实现产品差异化，同时降低手术结果的差异性。同时，多样化材料组合，包括可生物降解材料和复合材料，可以解决临床医生偏好的差异性和长期安全问题。重要的是，製造商必须建立临床项目，以产生可靠的真实世界数据和外科医生主导的证据，从而支持产品采用和支付方对话。

从营运角度来看，企业应审查筹资策略，以降低关税风险和物流风险，包括区域组装和策略性供应商多元化等选项。商业性，根据医院、门诊手术中心和专科诊所的需求客製化分销策略可以提高市场渗透率。这可以包括将专科医生直销与高周转率耗材的线上订购选项相结合的混合模式。最后，投资于全面的培训、测试和基于价值的合约可以加强与医疗保健提供者的关係，并将医疗设备嵌入其护理路径中，从而在竞争格局中创造持久优势。

一种透明的调查方法，结合定性专家访谈、监管和临床文献综述以及情境分析检验策略结论和建议

本研究将对外科专家、采购主管和设备工程师的定性访谈与对监管文件、临床文献和公开的机构采购惯例的二次分析相结合。调查方法和资料来源强调跨资料来源的三角测量，以确保研究结果既能反映临床实际情况，又能兼顾商业性约束。关键输入包括：结构化访谈（旨在揭示从业者偏好）、采购和培训项目的案例研究分析，以及对设备设计和材料的技术评审（旨在评估性能权衡）。

分析技术包括比较情境分析（用于评估资费变化和分销策略的影响），以及细分映射（用于识别优先应用和最终用途丛集）。品质保证流程包括来源检验和专家评审小组，以支援解读并完善建议的行动。这种方法无需依赖专有市场规模，即可为产品开发、上市规划和组织设计提供实际的洞察。

结论总结强调，实证创新、供应链弹性和综合商业化对于实现持续的临床和商业性成功至关重要

总而言之，吻合器市场的特点是临床创新、材料科学进步和不断变化的商业性压力之间的动态相互作用。要在这个市场取得成功，需要同时专注于提供可重复的手术结果，并建立一个能够适应当地监管和经济波动的、有弹性的、循证的商业模式。将强大的器材、多样化的材料选择和强大的临床培训项目整合成一个连贯的价值提案的利益相关人员，将最有能力满足临床医生的需求和机构的采购标准。

展望未来，企业应维持供应链规划的敏捷性，并优先考虑能够加速临床认可的伙伴关係。透过使产品蓝图与微创治疗的程序趋势保持一致，并投资于买家所需的真实世界证据，製造商和投资者可以创造永续的竞争差异化，并帮助改善不同医疗环境中的患者治疗效果。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 机器人吻合装置在结直肠手术中的广泛应用，采用增强型关节和精密机器人
  • 生物可吸收聚合物技术在血管和胃肠道吻合术中的整合，以减少长期併发症
  • 开发具有即时洩漏侦测和术后监测功能的物联网吻合系统
  • 推广使用一次性吻合器，以最大限度地减少交叉污染并简化医院的手术工作流程
  • 实施 3D 列印的患者专用吻合环，以改善复杂切除术中的贴合度和密封性。
  • 监管部门的核准推动了雷射和先进能量吻合口封闭设备在关键市场的商业化
  • 利用高频超音波引导开发微创腹腔镜吻合平台，可实现精确的组织近似
  • 增加对外科医生培训模拟器和虚拟实境模组的投资，以掌握先进的吻合装置技术
  • 随着医疗保健基础设施的不断扩大，亚太地区对具有成本效益的一次性医疗设备的需求日益增长。
  • 重点介绍健康经济学研究，证明新的吻合技术可以提高成本效益并减少住院时间

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章吻合器市场（按应用）

  • 心血管系统
    • 冠状动脉
    • 血管
  • 消化器官系统
    • 冒号
    • 食道
    • 胃

9. 吻合器材市场（依最终用途）

  • 门诊手术中心
  • 医院
  • 专科诊所

第 10 章 吻合器市场（依技术）

  • 手动的
  • 供电

第 11 章吻合器市场（依手术类型）

  • 微创
  • 开放性手术

第 12 章吻合器市场（依通路）

  • 直销
  • 网上销售
  • 第三方经销商

第十三章 吻合器市场（依材料类型）

  • 可生物降解
  • 合成的
  • 钛

第十四章吻合器市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章吻合器市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 吻合器市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • Stryker Corporation
    • Getinge AB
    • Terumo Corporation
    • ConMed Corporation
    • Cardinal Health, Inc.
    • Teleflex Incorporated
    • Baxter International Inc.
Product Code: MRR-431F213C91D8

The Anastomosis Devices Market is projected to grow by USD 5.71 billion at a CAGR of 8.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.04 billion
Estimated Year [2025] USD 3.29 billion
Forecast Year [2032] USD 5.71 billion
CAGR (%) 8.19%

Comprehensive introduction to the contemporary anastomosis devices landscape highlighting clinical drivers, innovation vectors, and procurement priorities for healthcare systems

The anastomosis devices sector stands at an inflection point as clinical demand for improved surgical outcomes converges with rapid device-level innovation. This report opens by framing the contemporary landscape in which surgeons, hospital administrators, and device manufacturers navigate an increasingly complex set of clinical, regulatory, and commercial considerations. Building on sustained improvements in instrument ergonomics, tissue-compatible materials, and procedure-specific tooling, stakeholders are recalibrating procurement and product road maps to reflect evolving clinical preferences and procedural workflows.

As minimally invasive techniques become standard of care across a widening range of cardiovascular and gastrointestinal procedures, device developers are responding with systems that emphasize reproducibility, reduced operative time, and enhanced tissue healing. Concurrently, payers and health systems are placing greater emphasis on value-based outcomes. Consequently, manufacturers must demonstrate not only technical performance but also integration with care pathways, training programs, and inventory management. This introduction establishes the core themes examined throughout the report and orients readers to the major drivers shaping near-term clinical adoption and commercial competition.

Detailed analysis of the technological, clinical, and regulatory shifts reshaping competitive advantage and adoption dynamics in the anastomosis devices market

The anastomosis devices landscape is undergoing transformative shifts driven by convergent forces in technology, clinical practice, and supply chain resilience. On the technology front, powered instrumentation and intelligent device interfaces are improving precision and consistency across complex anastomoses, while advances in biodegradable and composite materials are enhancing tissue integration and reducing long-term foreign body reactions. These technological shifts are not isolated; they influence training programs, procedural protocols, and device servicing models, necessitating a holistic approach to commercialization.

Clinically, surgeons are increasingly favoring techniques that minimize tissue trauma and shorten recovery, which has catalyzed broader adoption of minimally invasive approaches. As hospitals and ambulatory surgical centers refine perioperative pathways to optimize throughput and patient experience, device suppliers must align product development with the evolving cadence of care. Meanwhile, regulatory scrutiny and greater emphasis on post-market surveillance are elevating quality assurance and evidence-generation as commercial imperatives. Taken together, these trends are reshaping competitive advantage, where differentiation increasingly depends on a combination of clinical evidence, integrated services, and adaptable distribution models.

Insightful examination of how new United States tariff policies for 2025 are influencing manufacturing footprints, distribution strategies, and procurement dynamics in device supply chains

The introduction of new tariff measures in the United States for 2025 has introduced an added layer of complexity to supply chain and pricing strategies for device manufacturers and health system purchasers. Tariff adjustments influence procurement decisions across distribution channels, compel reassessment of manufacturing footprints, and shape negotiations between suppliers and institutional buyers. In response, many manufacturers are examining near-shoring, regional assembly hubs, and diversified sourcing to mitigate cost pressure while maintaining quality controls and lead-time reliability.

Beyond direct cost implications, tariffs can affect channel dynamics by altering the relative competitiveness of direct sales versus third-party distribution, and by incentivizing digital and online sales channels that reduce middle-tier costs. Healthcare providers are evaluating total cost of ownership with greater scrutiny, factoring in logistics risk, expected device longevity tied to material selection, and potential regulatory compliance costs. In short, tariff-driven shifts are reinforcing the importance of supply chain agility and contractual flexibility as central components of commercial strategy in the anastomosis devices sector.

In-depth segmentation-driven insights revealing clinical indications, end-use environments, technology types, procedure approaches, distribution channels, and material choices shaping demand

Segmentation provides the analytical framework to understand where innovation and demand converge across clinical and commercial axes. Based on application, the market is studied across cardiovascular and gastrointestinal procedures, with cardiovascular further divided into coronary and vascular, and gastrointestinal split into colorectal, esophageal, and gastric; this structure highlights how clinical indications drive device design priorities such as lumen size compatibility, reinforcement strategies, and hemostasis control. Based on end use, the market is studied across ambulatory surgical center, hospitals, and specialty clinic settings, revealing divergent procurement behaviors driven by case mix, capital budgets, and sterilization resources.

Drawing on technology segmentation, the market is studied across manual and powered solutions, enabling differential assessments of usability, training burden, and procedure time impacts. Based on procedure type, the market is studied across minimally invasive and open surgery approaches, which clarifies adoption trajectories as minimally invasive techniques continue to displace traditional open procedures for many indications. Based on distribution channel, the market is studied across direct sales, online sales, and third party distributors, which surfaces channel economics, service expectations, and aftermarket support requirements. Lastly, based on material type, the market is studied across biodegradable, composite, and titanium options to capture trade-offs between tissue compatibility, mechanical integrity, and long-term implant behavior. Together, these segmentations illuminate where clinical needs, reimbursement dynamics, and operational realities intersect to create pockets of opportunity and competitive pressure.

Strategic regional perspective on how diverse healthcare systems across the Americas, Europe Middle East & Africa, and Asia-Pacific require tailored commercialization tactics and regulatory strategies

Regional dynamics are central to strategic planning for product development, regulatory strategy, and commercial deployment. In the Americas, healthcare systems display a mix of advanced tertiary centers and community hospitals where purchasing decisions are influenced by integrated care networks, reimbursement models, and emphasis on bundled payment outcomes; this environment favors systems with robust clinical evidence and scalable training programs. In Europe, Middle East & Africa, regulatory heterogeneity and varying hospital procurement structures lead manufacturers to pursue tailored market entry strategies that balance centralized approvals with local partnerships, while cost-sensitivity in certain markets encourages modular product offerings and flexible commercial models.

Asia-Pacific markets present a diverse set of growth and adoption patterns driven by rising surgical capacity, expansion of minimally invasive programs, and government-led healthcare investments. Suppliers engaging these markets often combine localized manufacturing or assembly with collaborative training and clinical education initiatives to accelerate adoption. Across all regions, differences in supply chain resilience, tariff exposure, and distribution ecosystems require companies to adopt region-specific playbooks that integrate regulatory foresight, strategic partnerships, and adaptable pricing structures to succeed in a fragmented global landscape.

Authoritative overview of competitive dynamics showing how platform strategies, clinical evidence generation, and strategic partnerships determine market leadership in anastomosis solutions

Competitive dynamics in the anastomosis devices space are shaped by a mix of established medical device firms and agile specialized innovators. Leading companies are focusing on platform development that integrates instrumentation, consumables, and procedural training to create sticky relationships with surgical teams and hospital systems. These firms are investing in clinical evidence generation, often through multi-center studies and post-market registries, to demonstrate comparative performance and to support reimbursement discussions. At the same time, smaller, technology-focused entrants are pursuing niche applications with unique material science or automation features that address specific clinical pain points.

Partnerships and strategic alliances are increasingly common, enabling larger organizations to augment product portfolios with targeted technologies while providing scale and distribution reach. Concurrently, OEM and contract manufacturers are evolving from pure production partners into co-development collaborators, offering expertise in device engineering, regulatory navigation, and cost optimization. The overall competitive environment rewards companies that can combine clinical credibility with operational excellence in manufacturing, supply chain, and customer support.

Actionable strategic recommendations for device makers to align innovation, clinical evidence, and resilient commercial models to secure durable adoption across care settings

Industry leaders should prioritize an integrated approach that aligns product innovation with clinical workflows, supply chain resilience, and evidence generation. Investing in powered device platforms and intuitive user interfaces can reduce variance in surgical outcomes while differentiating offerings in hospital and ambulatory settings. In parallel, diversifying material portfolios to include biodegradable and composite options will address clinician preference variability and long-term safety considerations. Importantly, manufacturers should structure clinical programs that generate robust real-world data and surgeon-led evidence to support adoption and payer dialogue.

From an operational perspective, firms must reassess sourcing strategies to mitigate tariff exposure and logistics risk, including options for regional assembly and strategic vendor diversification. Commercially, tailoring distribution strategies to the needs of hospitals, ambulatory surgical centers, and specialty clinics will improve market penetration; this can include hybrid models combining direct specialist sales with online ordering options for high-turn consumables. Finally, investing in comprehensive training, proctoring, and value-based contracting will strengthen provider relationships and embed devices within care pathways, creating durable advantages in a competitive landscape.

Transparent research methodology combining qualitative expert interviews, regulatory and clinical literature review, and scenario analysis to validate strategic conclusions and recommendations

This study synthesizes primary qualitative interviews with surgical specialists, procurement leaders, and device engineers alongside secondary analysis of regulatory filings, clinical literature, and publicly available institutional procurement practices. The methodology emphasizes triangulation across data sources to ensure findings reflect both clinical realities and commercial constraints. Key inputs include structured interviews to surface practitioner preferences, case study analysis of procurement and training programs, and technical reviews of device designs and materials to assess performance trade-offs.

Analytical techniques incorporate comparative scenario analysis to evaluate impacts of tariff changes and distribution strategies, as well as segmentation mapping to identify high-priority application and end-use clusters. Quality assurance processes included source validation and expert review panels to corroborate interpretations and to refine recommended actions. This approach produces insights that are actionable for product development, go-to-market planning, and organizational design without relying on proprietary market sizing.

Concluding synthesis emphasizing the imperative for evidence-backed innovation, supply chain resilience, and integrated commercialization to achieve sustained clinical and commercial success

In conclusion, the anastomosis devices sector is characterized by dynamic interplay between clinical innovation, material science advances, and shifting commercial pressures. Success in this market requires a dual focus on delivering reproducible surgical performance and on building resilient, evidence-backed commercial models that can adapt to regional regulatory and economic variability. Stakeholders that integrate powered instrumentation, versatile material options, and strong clinical training programs into a coherent value proposition will be best positioned to meet clinician needs and institutional purchasing criteria.

Moving forward, companies should maintain agility in supply chain planning and prioritize partnerships that accelerate clinical acceptance. By aligning product road maps with the procedural trends toward minimally invasive care and by investing in the real-world evidence that buyers demand, manufacturers and investors can create sustainable competitive differentiation and support improved patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Widespread adoption of robotic assisted anastomosis devices for colorectal procedures using enhanced articulation and precision robotics
  • 5.2. Integration of bioabsorbable polymer technologies in vascular and gastrointestinal anastomosis for reduced long term complications
  • 5.3. Development of IoT enabled anastomosis systems with real time leak detection and postoperative monitoring capabilities
  • 5.4. Expansion of single use anastomosis staplers to minimize cross contamination and streamline surgical workflow in hospitals
  • 5.5. Implementation of 3D printed patient specific anastomotic rings to improve fit and sealing performance in complex resections
  • 5.6. Regulatory approvals driving the commercialization of laser based and advanced energy anastomosis sealing devices across major markets
  • 5.7. Growth of minimally invasive laparoscopic anastomosis platforms with high frequency ultrasound guidance for precise tissue approximation
  • 5.8. Increased investment in surgeon training simulators and virtual reality modules for mastering advanced anastomosis device techniques
  • 5.9. Rising demand in Asia Pacific for cost effective disposable anastomosis devices supported by expanding healthcare infrastructure
  • 5.10. Focus on health economic studies demonstrating improved cost effectiveness and reduced length of stay with novel anastomosis technology

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anastomosis Devices Market, by Application

  • 8.1. Cardiovascular
    • 8.1.1. Coronary
    • 8.1.2. Vascular
  • 8.2. Gastrointestinal
    • 8.2.1. Colorectal
    • 8.2.2. Esophageal
    • 8.2.3. Gastric

9. Anastomosis Devices Market, by End Use

  • 9.1. Ambulatory Surgical Center
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Anastomosis Devices Market, by Technology

  • 10.1. Manual
  • 10.2. Powered

11. Anastomosis Devices Market, by Procedure Type

  • 11.1. Minimally Invasive
  • 11.2. Open Surgery

12. Anastomosis Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online Sales
  • 12.3. Third Party Distributors

13. Anastomosis Devices Market, by Material Type

  • 13.1. Biodegradable
  • 13.2. Composite
  • 13.3. Titanium

14. Anastomosis Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anastomosis Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anastomosis Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Johnson & Johnson
    • 17.3.2. Medtronic plc
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. Stryker Corporation
    • 17.3.5. Getinge AB
    • 17.3.6. Terumo Corporation
    • 17.3.7. ConMed Corporation
    • 17.3.8. Cardinal Health, Inc.
    • 17.3.9. Teleflex Incorporated
    • 17.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANASTOMOSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 312. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 313. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 314. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 315. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 318. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 319. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 323. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION ANA